Bacillus Calmette-Guérin
Drug timelines are a Plus or Pro feature.
21 regulatory and trial events tracked for Bacillus Calmette-Guérin, covering 2011-09-28 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: A Study of TAR-200 in Combination With Cetrelimab or TAR-200 Alone Versus Intravesical Bacillus Calmette-Guérin (BCG) in Participants With BCG-naïve High-risk Non-muscle Invasive Bladder Cancer (HR-NMIBC) [Phase 3]